Is a reactivation EBV (Epstein-Barr Virus) possbilby involved in Long-COVID ? 

EBV (Epstein-Barr Virus) is a species of human pathogenic, enveloped, double-stranded DNA virus of the family Herpesviridae. Also known as infectious mononucleosis, is caused by the Epstein-Barr virus (EBV), which belongs to the herpesvirus family. 

Almost over 80% of the population have Epstein Bar Virus (EBV) in them without feeling any symptoms. Others have very severe symptoms of lymphatic swelling, headache, sore throat, liver strain, swelling of the spleen, and deep prolonged fatigue (so-called CFS).

Long-COVID & EBV research from US study

Researchers led by Jeffrey Gold of the World Organization in the USA have now investigated (see Study: https://www.mdpi.com/2076-0817/10/6/763), which role reactivation may play in long covid patients or also influence the intensity of covid disease.

EBV reactivation was found in 66.7% of 30 patients with long-term COVID-19 symptoms whose EBV status was determined.

According to the research team, ganciclovir is a suitable treatment. One of the few antiviral agents in the pharmaceutical industry.

What can I do ?

Alternative medicine has also taken an interest in the subject. For example, micro-immunotherapy has been dealing with the (re)activation of EBV in the blood for a very long time and as its main focus. What are the reasons and how can (re)activation be contained and sustainably influenced?

Strengthening the immune system through micro-immunotherapy is one approach.

As a pharmacist and non-medical practitioner, I recommend my customers with viral infections: Labo Life 2L EID | Omni-Biotic Pro-Vi | Orthomol Hair intense | Labo Life 2L MIREG

For more information please do not hesitate to contact me.